The company also announced that it will suspend its current home sleep testing services while it explores new innovations and options...
The two main applications are monitoring of patients with implantable cardiac rhythm management devices and monitoring of patients with sleep therapy devices.
Integration between the two platforms provides comprehensive health data access for healthcare organizations seeking to develop innovative treatments.
The system offers monitoring capabilities for caregivers, messaging, emergency response integration, wellness challenges, medication reminders and more.
Called Vera, it is designed to help people recovering from injuries do their physical therapy from home, while allowing therapists to collect patients' data.
Called SmartLinx Vitals Plus, the solution integrates vital signs monitoring, documentation and connectivity in a single device.
The company makes a wireless monitor that tracks patient position and movement which can be used to alert nursing staff as to which patients need to be moved.
Launching this fall, the Owlet Baby Monitor tracks an infant's vital signs like heart rate and oxygen levels to alert parents if their baby stops breathing.
The funds will be used to commercialize the second generation of the MoMe Kardia device that transmits a continuous feed of the patient's heart rhythm.
It is the first FDA-cleared product to receive the code PLB: Automated calculation of a summary index based on several individual measured vital sign inputs.